blog




  • Essay / The prevalence of anemia in patients with chronic kidney disease

    Hemoglobin levels in people with chronic kidney disease frequently fluctuate above or below recommended target levels over short periods of time , even if the calculated average hemoglobin remains within the target range of 11. to 12 g/dl. Say no to plagiarism. Get a tailor-made essay on “Why violent video games should not be banned”?Get the original essayAnemia is a common complication of chronic kidney disease. Optimal target hemoglobin levels for patients with different stages of chronic kidney disease are unclear. Anemia develops as a common complication of chronic kidney disease whose incidence and severity are proportional to the degree renal dysfunction3. Correction of anemia and maintenance of stable hemoglobin levels using erythropoiesis-stimulating agents (ESAs) is an important aspect of disease management. In clinical studies, increased hemoglobin concentration is associated with relief of anemia symptoms, improved quality of life, and decreased blood transfusion rates. Anemia develops as a common complication of chronic renal failure with an incidence and severity proportional to the degree of renal dysfunction. Correcting anemia and maintaining stable hemoglobin levels using erythropoiesis-stimulating agents (ESAs) is an important aspect of disease management.7 In clinical studies, a moderate increase in hemoglobin concentration is associated with relief of anemia symptoms, improvement in quality of life, and improvement in quality of life. decreased rate of blood transfusion. The National Kidney Foundation Kidney Disease Outcomes Quality Initiative (KDOQI) guidelines recommend targeting hemoglobin levels between 11 and 12 g/dl, while hemoglobin > 13 g/dl should be avoided.9 Multiple trials Recent randomized clinical trials have shown targeting hemoglobin levels >13 g/dl to “normalize” hemoglobin in chronic kidney disease may be associated with poor clinical outcomes,10 and a recent expert review of the Food and Drug Administration left the target range between 10 and 12 g/dl unchanged. refers to an absolute reduction in the total number of circulating red blood cells (RBCs). For practical purposes, anemia is considered when one or more of the following decreases: hemoglobin, hematocrit, or red blood cell (RBC) count. This condition is a laboratory result that signifies the presence of a disease or condition; Anemia should not be considered a diagnosis. Keep in mind: this is just a sample. Get a personalized article from our expert writers now. Get a Personalized Essay Anemia is generally grouped into three etiologic categories: decreased red blood cell production, increased red blood cell destruction, and blood loss. . Anemia of chronic disease and anemia of chronic kidney disease) both fall into the category of a decreased production of red blood cells. When the classification of anemia is based on red blood cell morphology, anemia due to chronic disease and chronic kidney failure generally fall under the classification of normochromic and normocytic anemias..